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Gynura procumbens (Lour.) Merr. (Family Asteraceae) is a medicinal plant commonly
found in tropical Asia countries such as China, Thailand, Indonesia, Malaysia, and
Vietnam. Traditionally, it is widely used in many different countries for the treatment of a
wide variety of health ailments such as kidney discomfort, rheumatism, diabetes mellitus,
constipation, and hypertension. Based on the traditional uses of G. procumbens, it
seems to possess high therapeutic potential for treatment of various diseases making
it a target for pharmacological studies aiming to validate and provide scientific evidence
for the traditional claims of its efficacy. Although there has been considerable progress in
the research on G. procumbens, to date there is no review paper gathering the reported
biological activities of G. procumbens. Hence, this review aims to provide an overview of
the biological activities of G. procumbens based on reported in vitro and in vivo studies.
In brief, G. procumbens has been reported to exhibit antihypertensive, cardioprotective,
antihyperglycemic, fertility enhancement, anticancer, antimicrobial, antioxidant, organ
protective, and antiinflammatory activity. The commercial applications of G. procumbens
have also been summarized in this paper based on existing patents. The data compiled
illustrate that G. procumbens is a potential natural source of compounds with various
pharmacological actions which can be utilized for the development of novel therapeutic
agents.
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INTRODUCTION
Gynura procumbens (Lour.)Merr. (Family Asteraceae), is a small plant∼1–3m in height. The stems
are fleshy and the leaves are ovate-elliptic or lanceolate (Rahman and Asad, 2013). It has scientific
synonym names such as Gynura sarmentosa DC and Cacalia sarmentosa Blume (Quattrocchi,
2012). The plant leaf is commonly consumed and scientifically it has been shown to be safe for
consumption (Rosidah et al., 2008). In Malaysia, the fresh leaves of G. procumbens are commonly
eaten raw and in Thailand, the leaves are also used for cooking (Kaewseejan et al., 2015). In Malay,
G. procumbens is called Sambung Nyawa which means “prolongation of life” whereas in Chinese,
it is called Bai Bing Cao which means “100 ailments” (Bodeker et al., 2009). This is because it has
been utilized in traditional medicine both systemically and for topical application for treatment of
different types of illnesses and diseases (Krishnan et al., 2015). For example, it is widely used to
relieve kidney discomfort in Indonesia and people have been using it for the treatment of fever
in Vietnam. In Thailand, it is commonly used to alleviate inflammation, rheumatism, and to cure
viral ailments (Wiart, 2006). The beneficial properties of G. procumbens have been attributed to the
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presence of bioactive compounds such as flavonoids and
glycosides in this plant (Akowuah et al., 2001, 2002).
Throughout the years, intensive research done on G.
procumbens has provided extensive scientific evidence of its
therapeutic potential. The present review aims to provide an
overview of the biological activities of G. procumbens with
reference to the available literature. The vast potential medical
applications of G. procumbens based on the consolidation of the




Hypertension is a key risk factor for several cardiovascular
diseases including coronary vascular disease and stroke (Lu
et al., 2012). Over the past few decades, significant effort has
been expended to explore medicinal plants with antihypertensive
therapeutic effect, includingG. procumbens (Lam et al., 1998). To
date, the administration of G. procumbens has been reported to
result in significant lowering of systolic blood pressure and mean
arterial pressure in hypertensive rats (Hoe and Lam, 2005; Kim
et al., 2006; Hoe et al., 2007). Additionally, the treatment with
G. procumbens extract has also resulted in significant decrease in
heart rate, strong negative chronotropic, and negative ionotropic
effects at rats’ right atrium and left atrium respectively (Hoe et al.,
2011; Kaur et al., 2012; Abrika et al., 2013).
Angiotensin (Ang)-converting enzyme is important for blood
pressure regulation. It converts Ang I into Ang II, the
peptide hormone with potent vasoconstrictive effects (Lote,
2006). Interestingly, the blood pressure-lowering effect of
G. procumbens was associated with its inhibitory effect on
angiotensin-converting enzyme activity (Hoe et al., 2007). In
addition to that, G. procumbens has direct inhibitory effect on
the activity of Ang II. This was demonstrated in the study
that reported the inhibition of Ang II- induced contraction
of aortic rings treated with fraction of G. procumbens (Poh
et al., 2013). In terms of mechanism of action, G. procumbens
possibly antagonizes the vasoconstrictive effect of Ang II through
endothelium-dependent pathways that involve the activation of
nitric oxide and prostaglandin release (Poh et al., 2013). This is
supported by the reduction of inhibitory effect of G. procumbens
aqueous fraction on Ang II-induced contraction in the presence
of cyclooxygenase inhibitor and endothelial nitric oxide synthase
inhibitor (Poh et al., 2013). This was also supported by another
research finding which found increased serum nitric oxide level
in hypertensive rats treated with G. procumbens extract (Kim
et al., 2006).
Another possible mechanism of the vasodilatory effect
of G. procumbens is inhibition of extracellular Ca2+ influx.
Vasocontraction caused by phenylephrine, calcium and
potassium chloride was shown to be antagonized by G.
procumbens extracts. This was probably due to the blocking of
receptor-operated and/or voltage dependent calcium channels
as well as opening of potassium channel (Hoe et al., 2011;
Ng et al., 2013). Therefore, G. procumbens potentially serves
as an antihypertensive agent with cardioprotective activity
due to its ability to target various mechanisms including the
renin-angiotensin system and calcium influx which are crucial
players in the pathophysiology of hypertensive conditions.
Antihyperglycemic Activity
G. procumbens is commonly used for diabetes treatment in
traditional medicine and its hypoglycemic effect has been
reported in in vivo studies (Hamid et al., 2004; Algariri et al.,
2014). One intriguing finding on G. procumbens, is its specificity
in inducing hypoglycemic effect only in diabetic animals as
it has been shown to cause a significant decrease in fasting
blood glucose levels and suppression of glucose elevation during
glucose tolerance test in diabetic rats but not normal rats (Zhang
and Tan, 2000; Algariri et al., 2013).
The effect of G. procumbens treatment on insulin level
has been investigated. Hamid et al. (2004) has reported the
stimulation of insulin secreting cell lines by G. procumbens
extract. However, the exposure of clonal pancreatic cells with
extract of G. procumbens did not stimulate insulin secretion
(Hassan et al., 2008). These contradicting results might be due
to the differing response of different cell lines when treated with
G. procumbens. Therefore, its effect on insulin secretion has
been further tested using in vivo studies. However, no significant
change has been observed in plasma insulin level in diabetic rats
treated with the extracts, implying that the hypoglycemic activity
ofG. procumbens does not rely on insulinotropic activity but may
instead be due to its extra-pancreatic effect (Hassan et al., 2008;
Lee et al., 2012).
Other pathways explored in the research include experiments
on the antidiabetic effect of G. procumbens focusing on glucose
uptake activity. The findings showed G. procumbens treatment
stimulated glucose uptake on 3T3 adipocytes. Furthermore, an
enhancement of activity was found in the presence of insulin
(Bohari et al., 2006). Further validation was then conducted via
in vivo work. The report showed an enhanced uptake of glucose
by muscle tissue of diabetic rats, indicating a direct effect of
G. procumbens extract on glucose uptake and utilization at the
peripheral levels (Hassan et al., 2010).
With reference to metabolic pathways, G. procumbens was
found to exert an effect on glucose metabolism in liver. It
was demonstrated to cause phosphorylation and inactivation of
glycogen synthase kinase 3 (GSK3) in the liver of diabetic rats,
suggesting that the hypoglycemic action of G. procumbens is due
to either direct or indirect effects on the upstream component(s)
activities in the insulin signaling pathway (Gansau et al., 2012).
In addition, it stimulated an increase in activity of glucokinase
and pyruvate dehydrogenase and phosphorylation of ATP-citrate
which are known to play roles in glucose metabolism (Kang
et al., 2015). Furthermore, an enhancement of liver hexokinase,
phosphofructokinase and fructose-1,6-bisphosphatase specific
activity were also found following treatment. This indicates
G. procumbens stimulated an increase in utilization of hepatic
glucose and decreased endogenous glucose production (Lee et al.,
2012).
There has also been work examining the hypoglycemic effect
of G. procumbens in combination with other herbal therapies.
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It was observed to achieve a stronger hypoglycemic effect when
G. procumbens was used together with Azadirachta indica or
Andrographis paniculata (Pramono and Nugroho, 2015). The
synergistic effect is postulated to be related to the diverse
range of active compounds present in the extract combination
(Sunarwidhi et al., 2014). Taken altogether, the current evidence
suggests the presence of bioactive principles which possess
insulinmimetic properties inG. procumbens (Hassan et al., 2010).
Sexual and Reproductive Function
Enhancement Activity
Aside from direct treatment of diabetes, research on G.
procumbens has also explored its potential in treating infertility,
which is one of the complications of diabetes (Ramalho-
Santos et al., 2008). G. procumbens was found to exhibit an
effect on sexual and reproductive function as the treatment
with G. procumbens significantly increased sperm count, sperm
motility, and reduced the percentage of sperm mortality of
diabetic rats (Sani et al., 2008). G. procumbens was also
demonstrated to have the aphrodisiac properties as evidenced
by an increase in mounting frequency of diabetic rats following
the treatment (Noor and Radzuan, 2012). In term of enzymatic
activity, G. procumbens was found to promote testicular lactate
dehydrogenase activity (Hakim et al., 2008). This finding can be
correlated to improved fertility because lactate dehydrogenase is
known to play a crucial role in spermatogenesis (Kaur and Bansal,
2004). Overall, studies clearly suggest that G. procumbens may
improve the reproductive function of infertile diabetic males,
particularly through an increase in sperm counts, quality, and
motility.
Anticancer Activity
G. procumbens has long been used as traditional treatment for
cancers such as leukemia, uterine, and breast cancers (Agustina
et al., 2006). This has prompted scientific exploration of the
antitumor activity of G. procumbens (Maw et al., 2011). Short
term (10 weeks) treatment of the ethanolic extract was found
to suppress the progression of nitroquinoline 1-oxide-induced
tongue carcinogenesis during initiation phase. Longer period
(26 weeks) of administration was demonstrated to lead to
high suppression of oral carcinogenesis (Agustina et al., 2006).
The ethanolic extract was also shown to be effective against
carcinogenetic effect of 7,12-dimethylbenz(a)antracene on liver
(Nisa et al., 2012). G. procumbens has been also tested on
osteosarcoma cell line. The treatment has resulted in inhibition
of cell proliferation and was observed to suppress the invasive
and migratory abilities of the cancer cells (Wang et al., 2013).
Recently, ethanolic extract of G. procumbens was shown to cause
about 80% decrease in azoxymethane-induced aberrant crypt
foci in rats which indicates potential in preventing colon cancer
(Shwter et al., 2014). G. procumbens has also demonstrated
its potential in preventing breast cancer. It was shown to
cause effective suppression in proliferation of breast cancer and
epithelial cells of mammary glands. Besides, the further studies
conducted has proven that the treatment of G. procumbens
was able to reduce the tumor incidence in the animals tested
(Meiyanto et al., 2007; Hew et al., 2013; Gofur et al., 2015).
Mechanistically, G. procumbens inhibits the initiation phase
of carcinogenesis. The treatment with ethanolic extract caused a
significant reduction in expression and activity of cytochrome P-
450 enzymes such as CYP3A4, CYP1A2, and CYP1A1 (Afandi
et al., 2014; Ghofur et al., 2015). This inhibition may lead
to a lower risk of cancer as it will result in a reduction
in the conversion of the respective procarcinogens to cancer
triggers (Afandi et al., 2014). In addition, G. procumbens
treatment has also been shown to stimulate expression of
glutathione-transferase which is involved in the detoxification of
carcinogenic compounds. These activities help to prevent cancer
formation at its initiation phase (Hamid et al., 2009; Ghofur et al.,
2015).
Cancer patients frequently consume herbal medicine as
complementary and alternative medicine while undergoing
chemotherapy (Cheng et al., 2010). In view of this, co-treatment
studies of G. procumbens and chemotherapy drugs have been
carried out. The combination of G. procumbens extract with
doxorubicin or 5-fluorouracil resulted in strong synergistic effect
against breast and colon cancer cells (Meiyanto and Jenie,
2007; Nurulita et al., 2011, 2012). However, co-treatment of G.
procumbens with cisplatin appeared to be antagonistic as this
combination failed to further suppress cancer cell proliferation
(Nurulita et al., 2011). This demonstrates that the concomitant
use of G. procumbens with different chemotherapy drugs might
result in variable treatment efficacy.
In general, the blockade of angiogenesis pathways will result
in inhibition of growth, invasion, and metastasis of tumor cells
(Hamid et al., 2011). G. procumbens was shown to exhibit
antiangiogenic activity as the treatment caused inhibition in
expression of vascular endothelial growth factor and prevented
formation of new blood vessels on fertilized chicken eggs (Jenie
et al., 2006; Hamid et al., 2013).
Based on the reported studies,G. procumbens appears to be an
effective chemotherapeutic agent against a wide range of cancer
cell types and it exerts its anticancer activities via the modulation
of various points of carcinogenesis including cancer initiation,
cell proliferation, metastasis, and angiogenesis.
Antimicrobial Activity
The increasing incidence of resistant strains of malaria, viruses
and also bacteria to currently available drugs makes the search for
alternative therapeutics from herbal plants a key area of interest
(Tan et al., 2015). The antiplasmodial activity of G. procumbens
was first reported by Vejanan et al. (2012). The research shows
that G. procumbens extract exhibits chemo-suppression effects
toward malarial parasite strains of Plasmodium falciparum 3D7
and Plasmodium berghei NK65; possibly via direct inhibition
of GSK3 or indirect action on pi3K/Akt pathway. Besides, the
ethanolic extract of aerial plant parts has been demonstrated
to exhibit virucidal and antireplicative activity against herpes
simplex virus HSV-1 and HSV-2. This was validated in a
clinical trial on patients with recurrent herpes labialis where
treatment with G. procumbens herbal gels reduced the number of
patients infected with HSV (Jarikasem et al., 2013). Meanwhile,
the antibacterial activities of G. procumbens have also been
tested with the extract exhibiting antibacterial activity against
gram-positive and gram-negative bacteria such as Bacillus
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cereus, Pseudomonas aeruginosa, Vibrio parahaemolyticus, and
Salmonella typhi (Rahman and Asad, 2013; Zheng et al., 2014).
The antifungal activity of G. procumbens against fungi such as
Candida albicans and Aspergillus niger was also observed. The
findings of these studies have provided supporting evidence that
substantiate the traditional use ofG. procumbens in the treatment
of infections by pathogens such as herpes simplex virus and
malaria parasites (Kaewseejan et al., 2012; Nasir et al., 2015).
Antioxidant Activity
The antioxidant activity of G. procumbens extracts was assessed
via DPPH assay to measure its free radical scavenging ability
(Akowuah et al., 2009; Afandi et al., 2014). In a comparative
study, the ethanol extract of G. procumbens exhibited the highest
percentage of DPPH inhibition (52.81%) among different types
of plant extracts that were tested (Maw et al., 2011). Meanwhile,
the reductive ability ofG. procumbens extract has also been tested
by using ferric reducing assay which has further proven the
antioxidant capacity possessed by this plant (Kaewseejan et al.,
2015).
Further examination of the antioxidant activity via a range of
different assays including trolox equivalent, β-carotene—linoleic
acid, and xanthine oxidase inhibitory assays have also been
explored. Based on the reported data, G. procumbens was
found to display substantial antioxidant activity (Rosidah et al.,
2008). Since lipid peroxidation is a common result of oxidative
stress, the antioxidative effect of G. procumbens was revealed
when it inhibited lipid peroxidation with the median effective
concentration of 2.75 mg/mL (Luerang et al., 2010; Kumar
and Pandey, 2013). In addition, the administration of methanol
extract prior to oxidative stress induction was able to reverse
the elevation of plasma lipid peroxidation in tested animals
(Akowuah et al., 2012). In order to differentiate the antioxidative
capacity of different parts of G. procumbens, a recent study was
conducted by Krishnan et al. (2015). The study revealed that
the root extract showed the highest antioxidant activity when
compared to the other parts of the plant. Based on the studies, G.
procumbens appears to be a potent source of natural antioxidants
probably due to its high phenolic content (Rosidah et al., 2008).
Organ Protective Effect
The protective effect of G. procumbens against damage
of body tissues and organs has also been evaluated. G.
procumbens was found to exert a gastroprotective effect as
the administration of ethanolic extract significantly lessened
the areas of ethanol-induced gastric ulcer in rats; with a
reduction of submucosal edema and infiltration of leucocytes
was observed (Mahmood et al., 2010). This finding has intrigued
the researchers to further explore the protective effect of G.
procumbens. In a study on skin damage, the antiphotoaging
property of G. procumbens has been discovered as it was found
to cause a significant inhibition in the expression of matrix
metalloproteinases induced by ultraviolet irradiation in human
dermal fibroflasts (Kim et al., 2011). The results obtained in
both studies demonstrated that its protective effects might be
associated with the ROS scavenging activity of G. procumbens
(Mahmood et al., 2010; Kim et al., 2011).
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FIGURE 1 | Biological activities of Gynura procumbens and its main bioactive constituents that contributed to the biological activities.
G. procumbens is also known to be effective in preventing
progressive renal diseases. The aqueous extract of plant was
found to cause inhibition of mesangial cell proliferation and
DNA synthesis. The suppression of regulator proteins for cell
proliferation was found to be responsible for this observed effect
(Lee et al., 2007). In addition, G. procumbens was found to
have a hepatoprotective effect as it was shown to attenuate the
ethanol-induced lipid accumulation in mice livers by modulating
lipid metabolism-related genes, particularly via MAPK/SREBP-
1c-dependent and -independent pathways (Li et al., 2015).
Based on these findings, G. procumbens has significant
potential as an organoprotective agent; mainly due to its
antioxidative properties which exert a regulatory effect at the level
of gene expression.
Antiinflammatory Activity
In Thai folk medicine, G. procumbens is commonly used to
treat inflammation (Wiart, 2006). It was shown to prevent
the increase in ear thickness of mice caused by croton
oil-induced inflammation (Iskander et al., 2002). Besides, topical
application of ethanol extract on the wounds of tested animals
showed significant dermal healing signs, less scar width, and
considerable faster healing rate when compared with control
group treated with saline (Zahra et al., 2011). Furthermore, the
histological analysis has also revealed there is a lesser amount of
inflammatory cells at the granulation tissue of wound area and
higher amount of collagen with angiogenesis.
Recently, the immunomodulatory activity of G. procumbens
has been tested using mice splenic cells. The treatment of
ethanolic leaf extracts of G. procumbens at 0.1 and 1.0µg/mL
caused higher proliferation of CD4+CD25+, CD4+CD62L−,
CD4+CD62L+, CD8+CD62L−, and CD8+CD62L+ T cells but
lower proliferation of B220+ cells when compared to the higher
dosage at 10µg/mL. However, at dosage of 10µg/mL, it was
shown to promote high proliferation of B cells. These results
have demonstrated that the concentration used in experiment
is the determining factor for whether G. procumbens acts as an
immunostimulant or immunosuppressant (Dwijayanti and Rifa’i,
2014, 2015).
Inflammation and the immune system are closely linked.
For instance, the immune system plays a crucial role in
the pathogenesis of the inflammatory disorder known as
atherosclerosis which can be treated using statins—drugs
with anti-inflammatory properties and immunomodulatory
properties (Shovman et al., 2002). Therefore, the
antiinflammatory and immunomodulatory activity of G.
procumbens may be utilized for the treatment of inflammatory
diseases or conditions that involve the immune system.
Commercial Uses
Among the existing patents related to G. procumbens, the
majority of them are for preparations of traditional Chinese
medicine intended for the treatment of various ailments
including uterine cancer (Liao, 2015), cervical spondylosis (Shi,
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2015), and chronic skin ulcer (Yang et al., 2015). Besides, it has
also been used as an ingredient in special diets for patients with
medical conditions such as heart (Chen et al., 2013b) and liver
disease (Chen et al., 2013a). In the food industry, it has been
incorporated into products such as tea (Hu, 2014; Liao et al.,
2014; Liu, 2015), kimchi (Jang, 2013), coffee powder (Park, 2015),
chocolate (Jang, 2014), candy (Xie, 2007c), and chewing gum
(Xie, 2010). The applications of G. procumbens in personal care
and cosmetic products have also been reported which including
hand-washing solution (Xie, 2009), hand sanitizer (Xie, 2007a),
oral spray (Xie, 2007b), facial masks (Yuan and She, 2014), and
skin care creams (Xie, 2007d). These patents have demonstrated
the high commercial value of G. procumbens and its variety of
uses in a number of industries.
CONCLUSION
In summary, G. procumbens has been demonstrated to have high
therapeutic value and has enormous potential for application
in the development of medical treatments as well as consumer
goods. Its diverse pharmacological effects and biological
properties (Table 1) are mainly attributed to its flavonoid
content (Figure 1). However, there is still limited knowledge
regarding the underlying mechanisms of action and exact
chemical constituents involved. Further research elucidating the
mechanisms underlying the biological activities is needed for
development of standardized drugs or herbal products.
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